Posttranscriptional inhibition of γ-adducin promotes the proliferation and migration of osteosarcoma cells

1. Ottaviani, G, Jaffe, N. The epidemiology of osteosarcoma. Cancer Treat Res 2009; 152: 3–13.
Google Scholar | Crossref | Medline2. Hughes, D . Strategies for the targeted delivery of therapeutics for osteosarcoma. Expert Opin Drug Deliv 2009; 6: 1311–1121.
Google Scholar | Crossref | Medline3. Bielack, S, Kempf-Bielack, B, Delling, G, et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: an analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J Clin Oncol 2002; 20: 776–790.
Google Scholar | Crossref | Medline4. Joshi, R, Gilligan, D, Otto, E, et al. Primary structure and domain organization of human alpha and beta adducin. J Cell Biol 1991; 115: 665–675.
Google Scholar | Crossref | Medline5. Xu, K, Zhong, G, Zhuang, X. Actin, spectrin, and associated proteins form a periodic cytoskeletal structure in axons. Science 2013; 339: 452–456.
Google Scholar | Crossref | Medline6. Dong, L, Chapline, C, Mousseau, B, et al. 35H, a sequence isolated as a protein kinase C binding protein, is a novel member of the adducin family. J Biol Chem 1995; 270: 25534–25540.
Google Scholar | Crossref | Medline7. Gilligan, D, Sarid, R, Weese, J. Adducin in platelets: activation-induced phosphorylation by PKC and proteolysis by calpain. Blood 2002; 99: 2418–2426.
Google Scholar | Crossref | Medline8. Kuhlman, P, Hughes, C, Bennett, V, et al. A new function for adducin: calcium/calmodulin-regulated capping of the barbed ends of actin filaments. J Biol Chem 1996; 271: 7986–7991.
Google Scholar | Crossref | Medline9. Matsuoka, Y, Li, X, Bennett, V. Adducin: structure, function and regulation. Cell Mol Life Sci 2000; 57: 884–895.
Google Scholar | Crossref | Medline10. Lechuga, S, Amin, P, Wolen, A, et al. Adducins inhibit lung cancer cell migration through mechanisms involving regulation of cell-matrix adhesion and cadherin-11 expression. Biochim Biophys Acta Mol Cell Res 2019; 1866: 395–408.
Google Scholar | Crossref | Medline11. Kiang, K, Zhang, P, Li, N, et al. Loss of cytoskeleton protein ADD3 promotes tumor growth and angiogenesis in glioblastoma multiforme. Cancer Lett 2020; 474: 118–126.
Google Scholar | Crossref | Medline12. Walters, D, Steinmann, P, Langsam, B, et al. Identification of potential chemoresistance genes in osteosarcoma. Anticancer Res 2008; 28: 673–679.
Google Scholar | Medline13. Ambros, V . The functions of animal microRNAs. Nature 2004; 431: 350–355.
Google Scholar | Crossref | Medline14. Wang, J, Zhao, B. MiR-23b-3p functions as a positive factor for osteoporosis progression by targeting CCND1 in MC3T3-E1 cells. In Vitro Cell Dev Biol Anim 2021; 57: 324–331.
Google Scholar | Crossref | Medline15. Li, R, Ruan, Q, Yin, F, et al. MiR-23b-3p promotes postmenopausal osteoporosis by targeting MRC2 and regulating the Wnt/β-catenin signaling pathway. J Pharm Sci 2021; 145: 69–78.
Google Scholar | Crossref16. Zhang, P, Liu, L, Yao, L, et al. Improved differentiation ability and therapeutic effect of miR-23a-3p expressing bone marrow-derived mesenchymal stem cells in mice model with acute lung injury. Int J Stem Cells 2021; 14: 229–239.
Google Scholar | Medline17. Yan, X, Zhang, M, Li, B, et al. RAI14 regulated by circNFATC3/miR-23b-3p axis facilitates cell growth and invasion in gastric cancer. Cell Transpl 2021; 30: 9636897211007055.
Google Scholar | SAGE Journals18. Zhu, R, Li, X, Ma, Y. miR-23b-3p suppressing PGC1α promotes proliferation through reprogramming metabolism in osteosarcoma. Cell Death Dis 2019; 10: 381.
Google Scholar | Crossref | Medline19. Ritchie, W . microRNA target prediction. Methods Mol Biol 2017; 1513: 193–200.
Google Scholar | Crossref | Medline20. Zhu, R, Li, X, Ma, Y. miR-23b-3p suppressing PGC1α promotes proliferation through reprogramming metabolism in osteosarcoma. Cell Death Dis 2019; 10: 381.
Google Scholar | Crossref | Medline21. Zhao, D, Lu, X, Wang, G, et al. Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer. Nature 2017; 542: 484–488.
Google Scholar | Crossref | Medline22. Baugh, E, Ke, H, Levine, A, et al. Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ 2018; 25: 154–160.
Google Scholar | Crossref | Medline23. Jiao, X, Zhang, S, Jiao, J, et al. Promoter methylation of SEPT9 as a potential biomarker for early detection of cervical cancer and its overexpression predicts radioresistance. Clin Epigenetics 2019; 11: 120.
Google Scholar | Crossref | Medline24. Young, M, Hsu, K, Lin, T, et al. The role of ubiquitin-specific peptidases in cancer progression. J Biomed Sci 2019; 26: 42.
Google Scholar | Crossref | Medline25. Zhang, Y, Chen, D, Zhang, G, et al. MicroRNA-23b-3p promotes pancreatic cancer cell tumorigenesis and metastasis via the JAK/PI3K and Akt/NF-κB signaling pathways. Oncol Lett 2020; 20: 160.
Google Scholar | Medline26. Zaman, M, Thamminana, S, Shahryari, V, et al. Inhibition of PTEN gene expression by oncogenic miR-23b-3p in renal cancer. PLoS One 2012; 7: e50203.
Google Scholar | Crossref | Medline

留言 (0)

沒有登入
gif